Cite
Views on the Desirability of Diagnosing Sporadic Cerebral Amyloid Angiopathy with Biological Evidence.
MLA
Abdulrahman, Herrer, et al. “Views on the Desirability of Diagnosing Sporadic Cerebral Amyloid Angiopathy with Biological Evidence.” Journal of Alzheimer’s Disease, vol. 87, no. 2, May 2022, pp. 807–16. EBSCOhost, https://doi.org/10.3233/JAD-220052.
APA
Abdulrahman, H., Smedinga, M., Verbeek, M. M., Klijn, C. J. M., Richard, E., & Perry, M. (2022). Views on the Desirability of Diagnosing Sporadic Cerebral Amyloid Angiopathy with Biological Evidence. Journal of Alzheimer’s Disease, 87(2), 807–816. https://doi.org/10.3233/JAD-220052
Chicago
Abdulrahman, Herrer, Marthe Smedinga, Marcel M. Verbeek, Catharina J.M. Klijn, Edo Richard, and Marieke Perry. 2022. “Views on the Desirability of Diagnosing Sporadic Cerebral Amyloid Angiopathy with Biological Evidence.” Journal of Alzheimer’s Disease 87 (2): 807–16. doi:10.3233/JAD-220052.